Jonas Botz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jonas Botz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Holger Fröhlich
Fraunhofer SCAI, Sankt Augustin, Germany
3 shared publications Anna‐Katharine Brem
University Hospital of Old Age Psychiatry, University of Bern, Bern, Switzerland
2 shared publicationsDag Aarsland
UK Dementia Research Institute, Institute of Psychiatry, Psychology & Neuroscience, King's College London., London, United Kingdom
2 shared publications- Diego Valderrama
Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Sankt Augustin Germany
2 shared publications Holger Fröhlich
Fraunhofer Institute for Algorithms and Scientific Computing SCAI, Sankt Augustin, Germany
2 shared publications- Jannis Guski
Department of Biomedical AI and Data Science, Fraunhofer Institute for Algorithms and Scientific Computing, Sankt Augustin, Germany
2 shared publications
Latest Publications
- Open Access
- 26 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e103344
Machine learning model for early dementia risk prediction using common risk factors in primary care settings
Background: Dementia poses an increasingly significant global health challenge, with projections indicating a dramatic rise in the number of affected individuals over the coming decades. This growing prevalence highlights the urgent need for early detection and intervention strategies. The 2024 Lancet Commission on dementia prevention, intervention, and care identified key risk factors for dementia, emphasizing the importance of early identification of high‐risk individuals to facilitate timely interventions that could potentially alter the disease's trajectory. These common risk factors can typically be gathered during routine general practitioner (GP) visits and do not necessitate specialized testing. Method: We developed and compared various machine learning models, including multi‐state‐models, random survival forest, CatBoost, and DeepHit, to predict the age dependent risk of a future dementia diagnosis (Figure 1). Our models were adjusted for the competing risk of deaths and trained on retrospective data from UK biobank, with external validation on data from the HUNT population study. All models incorporated common dementia risk factors as recommended by the Lancet Commission and were benchmarked against the previously published LIBRA score. Result: Our preliminary findings suggest that machine learning‐based risk models can accurately predict the likelihood of a future dementia diagnosis, achieving a 10‐fold cross‐validated area under the receiver operating characteristic curve (AUC) of 0.785 and 0.776 after 3 and 5 years, respectively. Conclusion: The models we developed can function as effective screening tools for estimating the risk of developing dementia 3 to 5 years in the future, utilizing easily accessible features at the GP level. The strength of these models lies in their incorporation of common risk factors that are routinely collected or readily available during standard GP visits. This approach represents a practical and scalable method for the early detection and prevention of dementia. By leveraging readily available data, these models could serve as valuable resources in primary care settings, potentially alleviating the global burden of dementia through timely interventions and personalized risk management strategies. Acknowledgment This Project Is Supported By The Innovative Health Initiative Joint Undertaking (IHIJU) Under Grant Agreement No 101132356. The JU Receives Support From The European Union's Horizon Europe Research And Innovation Programme. This Work Was Funded By UK Research AndInnovation (UKRI) Under The UK Government's Horizon Europe Funding Guarantee [UKRI Reference Number: 10083181]. In Switzerland The University Of Geneva Is Funded For PREDICTOM By The Swiss State Secretariat For Education Research And Innovation (SERI‐ Ref‐1131 52304).
- 26 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e103344
Open AccessMachine learning model for early dementia risk prediction using common risk factors in primary care settings
Background: Dementia poses an increasingly significant global health challenge, with projections indicating a dramatic rise in the number of affected individuals over the coming decades. This growing prevalence highlights the urgent need for early detection and intervention strategies. The 2024 Lancet Commission on dementia prevention, intervention, and care identified key risk factors for dementia, emphasizing the importance of early identification of high‐risk individuals to facilitate timely interventions that could potentially alter the disease's trajectory. These common risk factors can typically be gathered during routine general practitioner (GP) visits and do not necessitate specialized testing. Method: We developed and compared various machine learning models, including multi‐state‐models, random survival forest, CatBoost, and DeepHit, to predict the age dependent risk of a future dementia diagnosis (Figure 1). Our models were adjusted for the competing risk of deaths and trained on retrospective data from UK biobank, with external validation on data from the HUNT population study. All models incorporated common dementia risk factors as recommended by the Lancet Commission and were benchmarked against the previously published LIBRA score. Result: Our preliminary findings suggest that machine learning‐based risk models can accurately predict the likelihood of a future dementia diagnosis, achieving a 10‐fold cross‐validated area under the receiver operating characteristic curve (AUC) of 0.785 and 0.776 after 3 and 5 years, respectively. Conclusion: The models we developed can function as effective screening tools for estimating the risk of developing dementia 3 to 5 years in the future, utilizing easily accessible features at the GP level. The strength of these models lies in their incorporation of common risk factors that are routinely collected or readily available during standard GP visits. This approach represents a practical and scalable method for the early detection and prevention of dementia. By leveraging readily available data, these models could serve as valuable resources in primary care settings, potentially alleviating the global burden of dementia through timely interventions and personalized risk management strategies. Acknowledgment This Project Is Supported By The Innovative Health Initiative Joint Undertaking (IHIJU) Under Grant Agreement No 101132356. The JU Receives Support From The European Union's Horizon Europe Research And Innovation Programme. This Work Was Funded By UK Research AndInnovation (UKRI) Under The UK Government's Horizon Europe Funding Guarantee [UKRI Reference Number: 10083181]. In Switzerland The University Of Geneva Is Funded For PREDICTOM By The Swiss State Secretariat For Education Research And Innovation (SERI‐ Ref‐1131 52304).
- Open Access
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e102630
Risk stratification for the enrichment of potential high‐risk groups in a cognitive normal study population
Background: Dementia, particularly Alzheimer's disease, poses a significant health challenge worldwide. The PREDICTOM study aims to address this issue by establishing a comprehensive screening platform for dementia, with a specific focus on Alzheimer's disease. This innovative approach not only seeks to improve early detection but also evaluates novel biomarkers for their predictive value in assessing dementia risk. Method: The study utilizes a three‐tiered funneling process: Level 1 consists of at‐home screening; Level 2 encompasses a risk assessment that could potentially be carried out by general practitioners; and Level 3 entails a more comprehensive examination, which is usually conducted by a medical specialist. Following the FDA's enrichment trial concept, the screening phase targets the statistical overrepresentation of potential “high‐risk” patients for further assessment in levels 2 and 3. For this purpose, we develop two risk models using retrospective data. The first is a machine learning model based on the UK biobank, estimating individual risk of developing dementia within 3‐5 years post‐baseline, utilizing common risk factors identified by the Lancet commission. The second model, a normative model based on the existing PROTECT study cohort, analyzes age‐dependent cognitive decline (via the FLAME test battery) to assess individual abnormal cognitive function. Both models will be applied to the PREDICTOM participants and subsequently can be used to rank them according to their risk of developing dementia and/or of already showing signs of cognitive decline. To combine the predictions from these models, we will apply statistical consensus ranking using the FAST algorithm. Result: We will designate the top n = 400 patients as the “potential high‐risk” group for Level 2 inclusion, while the bottom n = 215 patients will serve as the “potential low‐risk” group. Due to logistical considerations, both groups will undergo Level 2/3 assessments in batches, culminating in Level 3 evaluations for amyloid beta positivity and cognitive impairment (Figure 1). Conclusion: The risk stratification ensures an enrichment of the potential high‐risk group, allowing for representative analyses of the novel biomarkers and a subsequent multi‐modal analysis accordingly. The results of this study could potentially lead to more effective screening and early intervention strategies for dementia. Acknowledgment: This Project Is Supported By The Innovative Health Initiative Joint Undertaking (IHIJU) Under Grant Agreement No101132356. The JU Receives Support From The European Union's Horizon Europe Research And Innovation Programme. This Work Was Funded By UK Research And Innovation (UKRI) Under The UK Government's Horizon Europe Funding Guarantee[UKRI Reference Number:10083181]. In Switzerland The University Of Geneva Is Funded For PREDICTOM By The Swiss State Secretariat For Education Research And Innovation (SERI‐ Ref‐1131 52304).
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e102630
Open AccessRisk stratification for the enrichment of potential high‐risk groups in a cognitive normal study population
Background: Dementia, particularly Alzheimer's disease, poses a significant health challenge worldwide. The PREDICTOM study aims to address this issue by establishing a comprehensive screening platform for dementia, with a specific focus on Alzheimer's disease. This innovative approach not only seeks to improve early detection but also evaluates novel biomarkers for their predictive value in assessing dementia risk. Method: The study utilizes a three‐tiered funneling process: Level 1 consists of at‐home screening; Level 2 encompasses a risk assessment that could potentially be carried out by general practitioners; and Level 3 entails a more comprehensive examination, which is usually conducted by a medical specialist. Following the FDA's enrichment trial concept, the screening phase targets the statistical overrepresentation of potential “high‐risk” patients for further assessment in levels 2 and 3. For this purpose, we develop two risk models using retrospective data. The first is a machine learning model based on the UK biobank, estimating individual risk of developing dementia within 3‐5 years post‐baseline, utilizing common risk factors identified by the Lancet commission. The second model, a normative model based on the existing PROTECT study cohort, analyzes age‐dependent cognitive decline (via the FLAME test battery) to assess individual abnormal cognitive function. Both models will be applied to the PREDICTOM participants and subsequently can be used to rank them according to their risk of developing dementia and/or of already showing signs of cognitive decline. To combine the predictions from these models, we will apply statistical consensus ranking using the FAST algorithm. Result: We will designate the top n = 400 patients as the “potential high‐risk” group for Level 2 inclusion, while the bottom n = 215 patients will serve as the “potential low‐risk” group. Due to logistical considerations, both groups will undergo Level 2/3 assessments in batches, culminating in Level 3 evaluations for amyloid beta positivity and cognitive impairment (Figure 1). Conclusion: The risk stratification ensures an enrichment of the potential high‐risk group, allowing for representative analyses of the novel biomarkers and a subsequent multi‐modal analysis accordingly. The results of this study could potentially lead to more effective screening and early intervention strategies for dementia. Acknowledgment: This Project Is Supported By The Innovative Health Initiative Joint Undertaking (IHIJU) Under Grant Agreement No101132356. The JU Receives Support From The European Union's Horizon Europe Research And Innovation Programme. This Work Was Funded By UK Research And Innovation (UKRI) Under The UK Government's Horizon Europe Funding Guarantee[UKRI Reference Number:10083181]. In Switzerland The University Of Geneva Is Funded For PREDICTOM By The Swiss State Secretariat For Education Research And Innovation (SERI‐ Ref‐1131 52304).
- Open Access
- 22 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0003058
A dynamic ensemble model for short-term forecasting in pandemic situations
During the COVID-19 pandemic, many hospitals reached their capacity limits and could no longer guarantee treatment of all patients. At the same time, governments endeavored to take sensible measures to stop the spread of the virus while at the same time trying to keep the economy afloat. Many models extrapolating confirmed cases and hospitalization rate over short periods of time have been proposed, including several ones coming from the field of machine learning. However, the highly dynamic nature of the pandemic with rapidly introduced interventions and new circulating variants imposed non-trivial challenges for the generalizability of such models. In the context of this paper, we propose the use of ensemble models, which are allowed to change in their composition or weighting of base models over time and could thus better adapt to highly dynamic pandemic or epidemic situations. In that regard, we also explored the use of secondary metadata—Google searches—to inform the ensemble model. We tested our approach using surveillance data from COVID-19, Influenza, and hospital syndromic surveillance of severe acute respiratory infections (SARI). In general, we found ensembles to be more robust than the individual models. Altogether we see our work as a contribution to enhance the preparedness for future pandemic situations.
- 22 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0003058
Open AccessA dynamic ensemble model for short-term forecasting in pandemic situations
During the COVID-19 pandemic, many hospitals reached their capacity limits and could no longer guarantee treatment of all patients. At the same time, governments endeavored to take sensible measures to stop the spread of the virus while at the same time trying to keep the economy afloat. Many models extrapolating confirmed cases and hospitalization rate over short periods of time have been proposed, including several ones coming from the field of machine learning. However, the highly dynamic nature of the pandemic with rapidly introduced interventions and new circulating variants imposed non-trivial challenges for the generalizability of such models. In the context of this paper, we propose the use of ensemble models, which are allowed to change in their composition or weighting of base models over time and could thus better adapt to highly dynamic pandemic or epidemic situations. In that regard, we also explored the use of secondary metadata—Google searches—to inform the ensemble model. We tested our approach using surveillance data from COVID-19, Influenza, and hospital syndromic surveillance of severe acute respiratory infections (SARI). In general, we found ensembles to be more robust than the individual models. Altogether we see our work as a contribution to enhance the preparedness for future pandemic situations.
- Open Access
A dynamic ensemble model for short-term forecasting in pandemic situations
During the COVID-19 pandemic, many hospitals reached their capacity limits and could no longer guarantee treatment of all patients. At the same time, governments endeavored to take sensible measures to stop the spread of the virus while at the same time trying to keep the economy afloat. Many models extrapolating confirmed cases and hospitalization rate over short periods of time have been proposed, including several ones coming from the field of machine learning. However, the highly dynamic nature of the pandemic with rapidly introduced interventions and new circulating variants imposed non-trivial challenges for the generalizability of such models. In the context of this paper, we propose the use of ensemble models, which are allowed to change in their composition or weighting of base models over time and can thus adapt to highly dynamic pandemic or epidemic situations. In that regard, we also explored the use of secondary metadata - Google searches - to inform the ensemble model. We tested our approach using surveillance data from COVID-19, Influenza, and hospital syndromic surveillance of severe acute respiratory infections (SARI). In general, we found ensembles to be more robust than the individual models. Altogether we see our work as a contribution to enhance the preparedness for future pandemic situations.
Open AccessA dynamic ensemble model for short-term forecasting in pandemic situations
During the COVID-19 pandemic, many hospitals reached their capacity limits and could no longer guarantee treatment of all patients. At the same time, governments endeavored to take sensible measures to stop the spread of the virus while at the same time trying to keep the economy afloat. Many models extrapolating confirmed cases and hospitalization rate over short periods of time have been proposed, including several ones coming from the field of machine learning. However, the highly dynamic nature of the pandemic with rapidly introduced interventions and new circulating variants imposed non-trivial challenges for the generalizability of such models. In the context of this paper, we propose the use of ensemble models, which are allowed to change in their composition or weighting of base models over time and can thus adapt to highly dynamic pandemic or epidemic situations. In that regard, we also explored the use of secondary metadata - Google searches - to inform the ensemble model. We tested our approach using surveillance data from COVID-19, Influenza, and hospital syndromic surveillance of severe acute respiratory infections (SARI). In general, we found ensembles to be more robust than the individual models. Altogether we see our work as a contribution to enhance the preparedness for future pandemic situations.
- Open Access
- 11 May 2023
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15
Spatial patterns of white matter hyperintensities: a systematic review
Background: White matter hyperintensities are an important marker of cerebral small vessel disease. This disease burden is commonly described as hyperintense areas in the cerebral white matter, as seen on T2-weighted fluid attenuated inversion recovery magnetic resonance imaging data. Studies have demonstrated associations with various cognitive impairments, neurological diseases, and neuropathologies, as well as clinical and risk factors, such as age, sex, and hypertension. Due to their heterogeneous appearance in location and size, studies have started to investigate spatial distributions and patterns, beyond summarizing this cerebrovascular disease burden in a single metric–its volume. Here, we review the evidence of association of white matter hyperintensity spatial patterns with its risk factors and clinical diagnoses.Design/methods: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement. We used the standards for reporting vascular changes on neuroimaging criteria to construct a search string for literature search on PubMed. Studies written in English from the earliest records available until January 31st, 2023, were eligible for inclusion if they reported on spatial patterns of white matter hyperintensities of presumed vascular origin.Results: A total of 380 studies were identified by the initial literature search, of which 41 studies satisfied the inclusion criteria. These studies included cohorts based on mild cognitive impairment (15/41), Alzheimer’s disease (14/41), Dementia (5/41), Parkinson’s disease (3/41), and subjective cognitive decline (2/41). Additionally, 6 of 41 studies investigated cognitively normal, older cohorts, two of which were population-based, or other clinical findings such as acute ischemic stroke or reduced cardiac output. Cohorts ranged from 32 to 882 patients/participants [median cohort size 191.5 and 51.6% female (range: 17.9–81.3%)]. The studies included in this review have identified spatial heterogeneity of WMHs with various impairments, diseases, and pathologies as well as with sex and (cerebro)vascular risk factors.Conclusion: The results show that studying white matter hyperintensities on a more granular level might give a deeper understanding of the underlying neuropathology and their effects. This motivates further studies examining the spatial patterns of white matter hyperintensities.
- 11 May 2023
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15
Open AccessSpatial patterns of white matter hyperintensities: a systematic review
Background: White matter hyperintensities are an important marker of cerebral small vessel disease. This disease burden is commonly described as hyperintense areas in the cerebral white matter, as seen on T2-weighted fluid attenuated inversion recovery magnetic resonance imaging data. Studies have demonstrated associations with various cognitive impairments, neurological diseases, and neuropathologies, as well as clinical and risk factors, such as age, sex, and hypertension. Due to their heterogeneous appearance in location and size, studies have started to investigate spatial distributions and patterns, beyond summarizing this cerebrovascular disease burden in a single metric–its volume. Here, we review the evidence of association of white matter hyperintensity spatial patterns with its risk factors and clinical diagnoses.Design/methods: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement. We used the standards for reporting vascular changes on neuroimaging criteria to construct a search string for literature search on PubMed. Studies written in English from the earliest records available until January 31st, 2023, were eligible for inclusion if they reported on spatial patterns of white matter hyperintensities of presumed vascular origin.Results: A total of 380 studies were identified by the initial literature search, of which 41 studies satisfied the inclusion criteria. These studies included cohorts based on mild cognitive impairment (15/41), Alzheimer’s disease (14/41), Dementia (5/41), Parkinson’s disease (3/41), and subjective cognitive decline (2/41). Additionally, 6 of 41 studies investigated cognitively normal, older cohorts, two of which were population-based, or other clinical findings such as acute ischemic stroke or reduced cardiac output. Cohorts ranged from 32 to 882 patients/participants [median cohort size 191.5 and 51.6% female (range: 17.9–81.3%)]. The studies included in this review have identified spatial heterogeneity of WMHs with various impairments, diseases, and pathologies as well as with sex and (cerebro)vascular risk factors.Conclusion: The results show that studying white matter hyperintensities on a more granular level might give a deeper understanding of the underlying neuropathology and their effects. This motivates further studies examining the spatial patterns of white matter hyperintensities.
- Open Access
Spatial Patterns of White Matter Hyperintensities: A Systematic Review
Background White matter hyperintensities are an important marker of cerebral small vessel diseases. This disease burden is commonly described as hyperintense areas in the cerebral white matter, as seen on T2-weighted fluid attenuated inversion recovery magnetic resonance imaging data. Studies have demonstrated associations with various cognitive impairments, neurological diseases, and neuropathologies, as well as clinical and risk factors, such as age, sex, and hypertension. Due to their heterogeneous appearance in location and size, studies have started to investigate spatial distributions and patterns, beyond summarizing this cerebrovascular disease burden in a single metric - its volume. Here, we review the evidence of association of white matter hyperintensity spatial patterns with its risk factors and clinical diagnoses. Design/Methods We have performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement. We used the standards for reporting vascular changes on neuroimaging criteria to construct a search string for literature search on PubMed. Studies written in English from the earliest records available until January 31st, 2023, were eligible for inclusion if they reported on spatial patterns of white matter hyperintensities of presumed vascular origin. Results A total of 372 studies were identified by the initial literature search, of which 37 studies satisfied the inclusion criteria. These studies included cohorts based on mild cognitive impairment (15/37), Alzheimer’s Disease (12/37), Dementia (5/37), Parkinson’s Disease (3/37), subjective cognitive decline (2/37). Additionally 4 of 37 studies investigated cognitive normal, older cohorts, two of which were population-based, or other clinical findings such as acute ischemic stroke or reduced cardiac output. Cohorts ranged from 32 to 882 patients/participants (median cohort size 191.5 and 50.2 % female (range: 17.9 - 81.3 %)). The studies included in this review have identified spatial heterogeneity of WMHs with various impairments, diseases, and pathologies as well as with sex and (cerebro)vascular risk factors. Conclusions The results show that studying white matter hyperintensities on a more granular level might give a deeper understanding of the underlying neuropathology and their effects. This motivates further studies examining the spatial patterns of white matter hyperintensities.
Open AccessSpatial Patterns of White Matter Hyperintensities: A Systematic Review
Background White matter hyperintensities are an important marker of cerebral small vessel diseases. This disease burden is commonly described as hyperintense areas in the cerebral white matter, as seen on T2-weighted fluid attenuated inversion recovery magnetic resonance imaging data. Studies have demonstrated associations with various cognitive impairments, neurological diseases, and neuropathologies, as well as clinical and risk factors, such as age, sex, and hypertension. Due to their heterogeneous appearance in location and size, studies have started to investigate spatial distributions and patterns, beyond summarizing this cerebrovascular disease burden in a single metric - its volume. Here, we review the evidence of association of white matter hyperintensity spatial patterns with its risk factors and clinical diagnoses. Design/Methods We have performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement. We used the standards for reporting vascular changes on neuroimaging criteria to construct a search string for literature search on PubMed. Studies written in English from the earliest records available until January 31st, 2023, were eligible for inclusion if they reported on spatial patterns of white matter hyperintensities of presumed vascular origin. Results A total of 372 studies were identified by the initial literature search, of which 37 studies satisfied the inclusion criteria. These studies included cohorts based on mild cognitive impairment (15/37), Alzheimer’s Disease (12/37), Dementia (5/37), Parkinson’s Disease (3/37), subjective cognitive decline (2/37). Additionally 4 of 37 studies investigated cognitive normal, older cohorts, two of which were population-based, or other clinical findings such as acute ischemic stroke or reduced cardiac output. Cohorts ranged from 32 to 882 patients/participants (median cohort size 191.5 and 50.2 % female (range: 17.9 - 81.3 %)). The studies included in this review have identified spatial heterogeneity of WMHs with various impairments, diseases, and pathologies as well as with sex and (cerebro)vascular risk factors. Conclusions The results show that studying white matter hyperintensities on a more granular level might give a deeper understanding of the underlying neuropathology and their effects. This motivates further studies examining the spatial patterns of white matter hyperintensities.
- Open Access
- 14 November 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10
Modeling approaches for early warning and monitoring of pandemic situations as well as decision support
The COVID-19 pandemic has highlighted the lack of preparedness of many healthcare systems against pandemic situations. In response, many population-level computational modeling approaches have been proposed for predicting outbreaks, spatiotemporally forecasting disease spread, and assessing as well as predicting the effectiveness of (non-) pharmaceutical interventions. However, in several countries, these modeling efforts have only limited impact on governmental decision-making so far. In light of this situation, the review aims to provide a critical review of existing modeling approaches and to discuss the potential for future developments.
- 14 November 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10
Open AccessModeling approaches for early warning and monitoring of pandemic situations as well as decision support
The COVID-19 pandemic has highlighted the lack of preparedness of many healthcare systems against pandemic situations. In response, many population-level computational modeling approaches have been proposed for predicting outbreaks, spatiotemporally forecasting disease spread, and assessing as well as predicting the effectiveness of (non-) pharmaceutical interventions. However, in several countries, these modeling efforts have only limited impact on governmental decision-making so far. In light of this situation, the review aims to provide a critical review of existing modeling approaches and to discuss the potential for future developments.